W. A. Vischer

949 total citations
40 papers, 698 citations indexed

About

W. A. Vischer is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, W. A. Vischer has authored 40 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 10 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in W. A. Vischer's work include Mycobacterium research and diagnosis (8 papers), Tuberculosis Research and Epidemiology (5 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (4 papers). W. A. Vischer is often cited by papers focused on Mycobacterium research and diagnosis (8 papers), Tuberculosis Research and Epidemiology (5 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (4 papers). W. A. Vischer collaborates with scholars based in Switzerland, United Kingdom and United States. W. A. Vischer's co-authors include O. Zák, Emanuel Suter, Erich G. Weirich, Renate Solf, H. K. Hochkeppel, R. Guggenheim, A Boutonnier, Anita Imm, Joëlle Fournier and Dietmar G. Braun and has published in prestigious journals such as Nature, Gastroenterology and Gut.

In The Last Decade

W. A. Vischer

36 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. A. Vischer Switzerland	14	274	187	164	113	104	40	698
F Kuze Japan	16	541 2.0×	143 0.8×	447 2.7×	69 0.6×	108 1.0×	35	1.1k
J. M. H. Pearson Ethiopia	20	673 2.5×	162 0.9×	334 2.0×	70 0.6×	302 2.9×	43	1.1k
N. L. Shipkowitz United States	19	239 0.9×	244 1.3×	484 3.0×	136 1.2×	59 0.6×	29	1.0k
C W Hanson United States	14	265 1.0×	189 1.0×	316 1.9×	85 0.8×	60 0.6×	20	708
Raymond P. Podzorski United States	10	165 0.6×	102 0.5×	159 1.0×	53 0.5×	126 1.2×	18	486
Tohru Takata Japan	19	268 1.0×	194 1.0×	148 0.9×	28 0.2×	236 2.3×	61	831
J. P. Maskell United Kingdom	17	195 0.7×	145 0.8×	263 1.6×	16 0.1×	45 0.4×	35	705
Birgitta Henriques Sweden	9	254 0.9×	116 0.6×	479 2.9×	22 0.2×	37 0.4×	11	715
Miriam Parizade Israel	9	138 0.5×	105 0.6×	163 1.0×	24 0.2×	56 0.5×	15	632
P. Smets France	14	115 0.4×	104 0.6×	155 0.9×	50 0.4×	16 0.2×	47	540

Countries citing papers authored by W. A. Vischer

Since Specialization

Citations

This map shows the geographic impact of W. A. Vischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. A. Vischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. A. Vischer more than expected).

Fields of papers citing papers by W. A. Vischer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. A. Vischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. A. Vischer. The network helps show where W. A. Vischer may publish in the future.

Co-authorship network of co-authors of W. A. Vischer

This figure shows the co-authorship network connecting the top 25 collaborators of W. A. Vischer. A scholar is included among the top collaborators of W. A. Vischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. A. Vischer. W. A. Vischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vischer, W. A., et al.. (2019). Relationship of Isoniazid to the Metabolism of Mycobacteria1.

Bardhan, Pradip Kumar, K. Gyr, Christoph Beglinger, et al.. (1992). Diagnosis of Bacterial Overgrowth after Culturing Proximal Small-Bowel Aspirate Obtained during Routine Upper Gastrointestinal Endoscopy. Scandinavian Journal of Gastroenterology. 27(3). 253–256. 39 indexed citations

Werth, Brian J., Christoph Beglinger, Jürgen Drewe, et al.. (1991). Helicobacter pylori infection in healthy people: a dynamic process?. Gut. 32(4). 347–350. 43 indexed citations

Wehrli, W., Wolfgang Zimmermann, W. G. Kump, et al.. (1987). CGP 4832, a new semisynthetic rifamycin derivative highly active against some gram-negative bacteria.. The Journal of Antibiotics. 40(12). 1733–1739. 21 indexed citations

Itin, Peter, Hans Stalder, & W. A. Vischer. (1986). Symmetrical Peripheral Gangrene in Disseminated Tuberculosis. Dermatology. 173(4). 189–195. 9 indexed citations

Lecaillon, J. B., et al.. (1980). Pharmacokinetic comparison of cefroxadin (CGP 9000) and cephalexin by simultaneous administration to humans. Antimicrobial Agents and Chemotherapy. 18(5). 656–660. 13 indexed citations

Zák, O., et al.. (1979). Antimicrobial Spectrum of Triclosan, a Broad-Spectrum Antimicrobial Agent for Topical Application. Dermatology. 158(1). 72–79. 70 indexed citations

Vischer, W. A., et al.. (1979). Antibiotic Sensitivity of Gonococcal Strains Isolated from Patients in Basel and Environs. Dermatology. 158(4). 249–256. 1 indexed citations

Vischer, W. A.. (1973). Comparative study of the efficacy of some sulphanilamide derivatives in clinical use against acute toxoplasmosis in the mouse.. 223(3). 398–408. 1 indexed citations

10.

Vischer, W. A.. (1972). Rapid Quantitative Evaluation of Chemotherapeutic Agents in Experimental Cystitis of Rats. Chemotherapy. 17(4). 293–304. 1 indexed citations

11.

Vischer, W. A., et al.. (1969). Antituberculosis activity of some nitrofuran derivatives. Journal of Pharmacy and Pharmacology. 21(7). 423–433. 6 indexed citations

12.

Vischer, W. A., et al.. (1960). SOME PROPERTIES OF CATECHOL PEROXIDASE OF MYCOBACTERIA BEARING ON ISONIAZID SUSCEPTIBILITY. Journal of Bacteriology. 80(4). 423–429. 5 indexed citations

13.

Vischer, W. A., et al.. (1958). Phenazinderivat mit starker tuberkulostatischer Wirkung. Lung. 119(1). 59–66. 2 indexed citations

14.

Vischer, W. A., et al.. (1958). Pyridoxin and the acute toxicity of isoniazid and other acid hydrazides in guinea pigs. Cellular and Molecular Life Sciences. 14(1). 22–23. 2 indexed citations

15.

Vischer, W. A., et al.. (1957). [The significance of peroxidase activity in Mycobacteria].. PubMed. 14(4). 243–6. 2 indexed citations

16.

Vischer, W. A., et al.. (1957). Relationship of isoniazid to the metabolism of mycobacteria; catalase and peroxidase.. PubMed. 75(1). 62–70. 11 indexed citations

17.

Vischer, W. A., et al.. (1957). Mode of action of isoniazid. Die Naturwissenschaften. 44(1). 11–12. 4 indexed citations

18.

Vischer, W. A.. (1957). In vitro-Untersuchungen über die tuberkulostatische Wirkung von Cyanessigsäurehydrazid. Lung. 116(7). 609–614.

19.

Vischer, W. A., et al.. (1956). Effect of isoniazid on catalase and peroxidase of tuberele bacilli in vitro. Die Naturwissenschaften. 43(20). 474–475. 2 indexed citations

20.

Vischer, W. A., et al.. (1951). [Modification of lung tissue after bronchography with contrast media containing carboxymethylcellulose].. PubMed. 81(44). 1077–80. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact